Pittsburgh, PA, United States of America

Suman Pathi

This inventor holds 1 USPTO granted patent and 4 published patent applications. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suman Pathi. Retrieved from https://idiyas.com/inventor/suman-pathi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suman Pathi and His Patent on KV7 Channel Activators.

Introduction

Suman Pathi is an inventor associated with Pittsburgh, Pennsylvania. His patent work includes a pharmaceutical invention focused on pyrazolyl compounds that activate KV7 channels.

Latest Patents

The provided information lists one patent for Suman Pathi: “Pyrazolyl Compounds as KV7 Channel Activators.” The patent describes optionally substituted pyrazolylacetamides, pharmaceutical compositions containing these compounds, and methods for treating a range of conditions. The conditions named include epilepsy, amyotrophic lateral sclerosis, pain, hyperexcitability, dyskinesia, dystonia, mania, tinnitus, neurodevelopmental disorders, smooth muscle contractility disorders, Dravet syndrome, and posttraumatic stress disorder. His listed patent total is 1 patent.

Career Highlights

Pathi’s listed invention concerns potential therapeutic applications of KV7 channel activators. The patent describes compounds and compositions intended for use in treating neurological, psychiatric, pain-related, and smooth muscle conditions.

Collaborations

The provided information names James S. Hale and Isis J. Amaye as some of Pathi’s coworkers. Their inclusion reflects a collaborative context for his patent-related work.

Conclusion

Suman Pathi’s listed patent presents pyrazolyl compounds and pharmaceutical compositions as potential approaches to treating a broad range of disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…